What to Watch. Dr Reddy’s Labs board to consider buyback today

The board of directors of Dr Reddy’s Laboratories will meet on Wednesday to consider a buyback of shares. According to the shareholding pattern for the December quarter, public shareholding in the company was at 74.43 per cent or 9.40 crore shares, while promoter holding was at 25.57 per cent or 4.36 crore shares. The group posted a net profit of ₹579.2 crore in Q3FY16 on a topline of ₹3,980.1 crore against a net profit of ₹574.5 crore in Q3FY15 on a topline of ₹3,877.2 crore on consolidated basis.